Trending Now - Supreme Court Grants Temporary Mail Access to Abortion Pill

WHO:

AP News - Justice Samuel Alito is involved in the case regarding mifepristone.

AP News - Louisiana is the state that filed a lawsuit concerning the abortion pill.

AP News - The Food and Drug Administration (FDA) is mentioned as the agency that regulates mifepristone.

AP News - Mainstream medical groups, the pharmaceutical industry, and Democratic members of Congress have expressed their views on the case.

WHAT:

CNN - The Supreme Court's new order extends the stay until "Thursday at 5 p.m. ET."

AP News - The Supreme Court is considering whether to allow restrictions on mifepristone to take effect.

ABC News - Justice Samuel Alito has extended an order that maintains access to the abortion pill mifepristone by mail and telehealth.

CNN - The Supreme Court's new order extends the stay until "Thursday at 5 p.m. ET."

NPR - The Supreme Court's order allows access to mifepristone through telemedicine for at least three more days.

CNN - The Supreme Court extended a short-term order allowing access to the abortion pill mifepristone through telehealth visits.

NBC News - The Supreme Court temporarily allowed full access to mifepristone while considering a case that could limit the drug's availability.

AP News - The Supreme Court is maintaining access to mifepristone through mail and pharmacies without requiring in-person doctor visits.

AP News - The current dispute involves a lawsuit from Louisiana aiming to roll back FDA rules on mifepristone.

WHERE:

AP News - The case is being deliberated in the U.S. Supreme Court.

WHEN:

CNN - The new order extends the stay until "Thursday at 5 p.m. ET."

AP News - The Supreme Court is considering whether to allow restrictions on mifepristone to take effect.

WHY:

NPR - The state of Louisiana argues that telemedicine access undermines the state's abortion ban.

AP News - Louisiana claims that the FDA's policy on mifepristone undermines its state ban on abortion.

AP News - The case is part of ongoing challenges to the safety and regulation of mifepristone, which has been contested for over 25 years.

HOW:

NBC News - The Supreme Court temporarily allowed full access to mifepristone while it considers a case that could limit availability of the drug.

AP News - The Supreme Court's order prevents restrictions imposed by a federal appeals court from taking effect for the time being.

(UPDATED May 12, 2026 07:50 UTC)

The Supreme Court has extended its stay on restrictions regarding mifepristone until Thursday at 5 p.m. ET, while it deliberates on whether those restrictions should take effect. Louisiana is arguing that telemedicine access to the drug undermines the state's abortion ban. In the meantime, the Court has temporarily allowed full access to mifepristone as it reviews the case that could impact the drug's availability.

(UPDATED May 12, 2026 01:29 UTC)

The Supreme Court has extended an order that maintains access to the abortion pill mifepristone by mail and telehealth, allowing this access through telemedicine for at least three more days. This stay will remain in effect until Thursday at 5 p.m. ET, as the Court considers a case related to the drug's availability, amid arguments from Louisiana that telemedicine access undermines the state's abortion ban.

(UPDATED May 11, 2026 23:17 UTC)

The U.S. Supreme Court has extended a short-term order allowing access to the abortion pill mifepristone through telehealth visits, while deliberating on a lawsuit from Louisiana that seeks to roll back FDA regulations on the drug. This temporary measure maintains access to mifepristone via mail and pharmacies without requiring in-person doctor visits, as the court considers whether to allow new restrictions to take effect. The case has drawn attention from mainstream medical groups, the pharmaceutical industry, and Democratic members of Congress, highlighting ongoing challenges to the safety and regulation of mifepristone that have persisted for over 25 years.